High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival

Lung cancer is the leading cause of cancer related death, and the past years’ improved insight into underlying molecular events has significantly improved outcome for specific subsets of patients. In particular, several new therapies that target protein kinases have been implemented, and many more a...

Descripción completa

Detalles Bibliográficos
Autores principales: Helland, Å., Brustugun, O. T., Nakken, S., Halvorsen, A. R., Dønnem, T., Bremnes, R., Busund, L. T., Sun, J., Lorenz, S., Solberg, S. K., Jørgensen, L. H., Vodak, D., Myklebost, O., Hovig, E., Meza‐Zepeda, L. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Tumor Immunology and Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450131/
https://www.ncbi.nlm.nih.gov/pubmed/28387924
http://dx.doi.org/10.1002/ijc.30726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450131/
https://www.ncbi.nlm.nih.gov/pubmed/28387924
http://dx.doi.org/10.1002/ijc.30726

Ejemplares similares